Cargando…

Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer

BACKGROUND: Majority of gastric cancers (GC) are diagnosed at advanced stages which contributes towards their poor prognosis. In view of this clinical challenge, identification of non-invasive biomarker for early diagnosis is imperative. Herein, we aimed to develop a non-invasive, liquid-biopsy base...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Souvick, Kanda, Mitsuro, Nomura, Sachiyo, Zhu, Zhongxu, Toiyama, Yuji, Taketomi, Akinobu, Goldenring, James, Baba, Hideo, Kodera, Yasuhiro, Goel, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826675/
https://www.ncbi.nlm.nih.gov/pubmed/35139874
http://dx.doi.org/10.1186/s12943-022-01527-7
_version_ 1784647476336132096
author Roy, Souvick
Kanda, Mitsuro
Nomura, Sachiyo
Zhu, Zhongxu
Toiyama, Yuji
Taketomi, Akinobu
Goldenring, James
Baba, Hideo
Kodera, Yasuhiro
Goel, Ajay
author_facet Roy, Souvick
Kanda, Mitsuro
Nomura, Sachiyo
Zhu, Zhongxu
Toiyama, Yuji
Taketomi, Akinobu
Goldenring, James
Baba, Hideo
Kodera, Yasuhiro
Goel, Ajay
author_sort Roy, Souvick
collection PubMed
description BACKGROUND: Majority of gastric cancers (GC) are diagnosed at advanced stages which contributes towards their poor prognosis. In view of this clinical challenge, identification of non-invasive biomarker for early diagnosis is imperative. Herein, we aimed to develop a non-invasive, liquid-biopsy based assay by using circular RNAs (circRNAs) as molecular biomarkers for early detection of GC. METHODS: We performed systematic biomarker discovery and validation of the candidate circRNAs in matched tissue specimens of GC and adjacent normal mucosa. Next, we translated the discovered circRNA based biomarker panel into serum samples in a training and validation cohort of GC patients (n = 194) and non-disease controls (n = 94) and evaluated their diagnostic performance. In addition, we measured the expression of circRNAs in serum samples of pre- and post-surgical GC patients and evaluated the specificity of circRNAs biomarker panel with respect to other gastro-intestinal (GI) malignancies. RESULTS: We identified 10-circRNAs in the discovery phase with subsequent validation in a pilot cohort of GC tissue specimens. Using a training cohort of patients, we developed an 8-circRNA based risk-prediction model for the diagnosis of GC. We observed that our biomarker panel robustly discriminated GC patients from non-disease controls with an AUC of 0.87 in the training, and AUC of 0.83 in the validation cohort. Notably, the biomarker panel could robustly identify even early-stage GC patients, regardless of their tumor histology (diffuse vs. intestinal). The decreased expression of circRNAs in post-surgery serum specimens indicated their tumor-specificity and their potential source of origin in the systemic circulation. CONCLUSIONS: We identified a panel of 8-circRNAs as non-invasive, liquid-biopsy biomarkers which might serve as potential diagnostic biomarkers for the early detection of GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01527-7.
format Online
Article
Text
id pubmed-8826675
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88266752022-02-10 Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer Roy, Souvick Kanda, Mitsuro Nomura, Sachiyo Zhu, Zhongxu Toiyama, Yuji Taketomi, Akinobu Goldenring, James Baba, Hideo Kodera, Yasuhiro Goel, Ajay Mol Cancer Research BACKGROUND: Majority of gastric cancers (GC) are diagnosed at advanced stages which contributes towards their poor prognosis. In view of this clinical challenge, identification of non-invasive biomarker for early diagnosis is imperative. Herein, we aimed to develop a non-invasive, liquid-biopsy based assay by using circular RNAs (circRNAs) as molecular biomarkers for early detection of GC. METHODS: We performed systematic biomarker discovery and validation of the candidate circRNAs in matched tissue specimens of GC and adjacent normal mucosa. Next, we translated the discovered circRNA based biomarker panel into serum samples in a training and validation cohort of GC patients (n = 194) and non-disease controls (n = 94) and evaluated their diagnostic performance. In addition, we measured the expression of circRNAs in serum samples of pre- and post-surgical GC patients and evaluated the specificity of circRNAs biomarker panel with respect to other gastro-intestinal (GI) malignancies. RESULTS: We identified 10-circRNAs in the discovery phase with subsequent validation in a pilot cohort of GC tissue specimens. Using a training cohort of patients, we developed an 8-circRNA based risk-prediction model for the diagnosis of GC. We observed that our biomarker panel robustly discriminated GC patients from non-disease controls with an AUC of 0.87 in the training, and AUC of 0.83 in the validation cohort. Notably, the biomarker panel could robustly identify even early-stage GC patients, regardless of their tumor histology (diffuse vs. intestinal). The decreased expression of circRNAs in post-surgery serum specimens indicated their tumor-specificity and their potential source of origin in the systemic circulation. CONCLUSIONS: We identified a panel of 8-circRNAs as non-invasive, liquid-biopsy biomarkers which might serve as potential diagnostic biomarkers for the early detection of GC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01527-7. BioMed Central 2022-02-09 /pmc/articles/PMC8826675/ /pubmed/35139874 http://dx.doi.org/10.1186/s12943-022-01527-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Roy, Souvick
Kanda, Mitsuro
Nomura, Sachiyo
Zhu, Zhongxu
Toiyama, Yuji
Taketomi, Akinobu
Goldenring, James
Baba, Hideo
Kodera, Yasuhiro
Goel, Ajay
Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title_full Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title_fullStr Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title_full_unstemmed Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title_short Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
title_sort diagnostic efficacy of circular rnas as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826675/
https://www.ncbi.nlm.nih.gov/pubmed/35139874
http://dx.doi.org/10.1186/s12943-022-01527-7
work_keys_str_mv AT roysouvick diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT kandamitsuro diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT nomurasachiyo diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT zhuzhongxu diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT toiyamayuji diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT taketomiakinobu diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT goldenringjames diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT babahideo diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT koderayasuhiro diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer
AT goelajay diagnosticefficacyofcircularrnasasnoninvasiveliquidbiopsybiomarkersforearlydetectionofgastriccancer